Cerebral small vessel disease, medial temporal lobe atrophy and cognitive status in patients with ischaemic stroke and transient ischaemic attack

European Journal of Neurology

Volumn 24, Issue 2, 2017, Pages 276-282

  Arba, F ^a,b   Quinn, T ^c   Hankey, G J ^d,e   Ali, M ^b   Lees, K R ^c   Inzitari, D ^a   Diener, H C ^e   Davis, S ^e   Ovbiagele, B ^e   Weir, C J ^e  

^a UNIVERSITY OF FLORENCE   (Italy)

^b QUEEN ELIZABETH UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e University of Glasgow ^*

Author keywords

Alzheimer's disease; cognitive disorders and dementia; medial temporal lobe atrophy; small vessel disease; stroke

Indexed keywords

AGED; ARTICLE; ATRIAL FIBRILLATION; BRAIN ATROPHY; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LACUNAR STROKE; MAJOR CLINICAL STUDY; MALE; MEDIAL TEMPORAL LOBE; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; TRANSIENT ISCHEMIC ATTACK; ATROPHY; CEREBROVASCULAR ACCIDENT; COMPLICATION; DIAGNOSTIC IMAGING; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGY; TEMPORAL LOBE;

AGED; ATROPHY; CEREBRAL SMALL VESSEL DISEASES; COGNITION; COGNITIVE DYSFUNCTION; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; STROKE; TEMPORAL LOBE;

EID: 85005992222     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.13191     Document Type: Article

References (26)

1. Winblad B, Amouyel P, Andrieu S, et al. Defeating Alzheimer's disease and other dementias: a priority for European science and society. Lancet Neurol 2016; 15: 455–532.
2. Scheltens P, Leys D, Barkhof F, et al. Atrophy of medial temporal lobes on MRI in ‘probable’ Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992; 55: 967–972.
3. Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol 2013; 12: 483–497.
4. Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42: 2672–2713.
5. Kuller LH, Lopez OL, Newman A, et al. Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology 2003; 22: 13–22.
6. Launer LJ, Ross GW, Petrovitch H, et al. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging 2000; 21: 49–55.
7. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 1999; 53: 1937–1942.
8. Leys D, Hénon H, Mackowiak-Cordoliani MA, Pasquier F. Poststroke dementia. Lancet Neurol 2005; 4: 752–759.
9. Brainin M, Tuomilehto J, Heiss WD, et al. Post-stroke cognitive decline: an update and perspectives for clinical research. Eur J Neurol 2015; 22: 229–238.
10. Ali M, Bath P, Brady M, et al. Development, expansion, and use of a stroke clinical trials resource for novel exploratory analyses. Int J Stroke 2012; 7: 133–138.
11. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischaemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35–41.
12. Bamford JM, Sandercock P, Warlow C, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1989; 20: 828.
13. Wardlaw JM, Smith EE, Biessels GJ, et al. STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013; 12: 822–838.
14. Van Swieten JC, Hijdra A, Koudstaal PJ, van Gijn J. Grading white matter lesions on CT and MRI: a simple scale. J Neurol Neurosurg Psychiatry 1990; 53: 1080–1083.
15. IST-3 collaborative group. Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the Third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial. Lancet Neurol 2015; 14: 485–496.
16. Potter GM, Chappell FM, Morris Z, et al. Cerebral perivascular spaces visible on magnetic resonance imaging: development of a qualitative rating scale and its observer reliability. Cerebrovasc Dis 2015; 39: 224–231.
17. Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189–198.
18. Lees R, Selvarajah J, Fenton C, et al. Test accuracy of cognitive screening tests for diagnosis of dementia and multidomain cognitive impairment in stroke. Stroke 2014; 45: 3008–3018.
19. Hénon H, Pasquier F, Durieu I, Pruvo JP, Leys D. Medial temporal lobe atrophy in stroke patients: relation to pre-existing dementia. J Neurol Neurosurg Psychiatry 1998; 65: 641–647.
20. Kebets V, Gregoire SM, Charidimou A, et al. Prevalence and cognitive impact of medial temporal atrophy in a hospital stroke service: retrospective cohort study. Int J Stroke 2015; 10: 861–867.
21. Jokinen H, Kalska H, Ylikoski R, et al. Medial temporal lobe atrophy and memory deficits in elderly stroke patients. Eur J Neurol 2004; 11: 825–832.
22. Scheltens P, Barkhof F, Valk J, et al. White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. Brain 1992; 115(Pt 3): 735–748.
23. Bastos-Leite AJ, van der Flier WM, van Straaten EC, Staekenborg SS, Scheltens P, Barkhof F. The contribution of medial temporal lobe atrophy and vascular pathology to cognitive impairment in vascular dementia. Stroke 2007; 38: 3182–3185.
24. Firbank MJ, Burton EJ, Barber R, et al. Medial temporal atrophy rather than white matter hyperintensities predict cognitive decline in stroke survivors. Neurobiol Aging 2007; 28: 1664–1669.
25. McGovern A, Pendlebury ST, Mishra NK, Fan Y, Quinn TJ. Test accuracy of informant-based cognitive screening tests for diagnosis of dementia and multidomain cognitive impairment in stroke. Stroke 2016; 47: 329–335.
26. Pendelbury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol 2009; 8: 1006–1018.